Oaktop Capital Management II L.P. Makes New Investment in Aspen Aerogels, Inc. $ASPN

Oaktop Capital Management II L.P. purchased a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPNFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,168,674 shares of the construction company’s stock, valued at approximately $32,769,000. Aspen Aerogels accounts for about 1.4% of Oaktop Capital Management II L.P.’s portfolio, making the stock its 6th largest holding. Oaktop Capital Management II L.P. owned 0.06% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in Aspen Aerogels during the second quarter worth about $33,457,000. Pallas Capital Advisors LLC purchased a new position in Aspen Aerogels during the second quarter worth about $69,000. Deutsche Bank AG acquired a new position in Aspen Aerogels in the 2nd quarter valued at about $2,359,000. Rice Hall James & Associates LLC acquired a new position in Aspen Aerogels in the 2nd quarter valued at about $10,368,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Aspen Aerogels in the 2nd quarter valued at approximately $682,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ASPN has been the topic of several analyst reports. Roth Capital reaffirmed a “buy” rating and set a $7.75 price target on shares of Aspen Aerogels in a research report on Friday, August 7th. B. Riley Financial reiterated a “buy” rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. Barclays lifted their target price on Aspen Aerogels from $4.00 to $5.00 and gave the company an “underweight” rating in a research report on Tuesday, August 11th. Finally, Wall Street Zen lowered Aspen Aerogels from a “hold” rating to a “sell” rating in a research note on Saturday. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $5.94.

View Our Latest Stock Report on ASPN

Aspen Aerogels Trading Down 0.3%

Shares of NYSE ASPN opened at $5.83 on Tuesday. Aspen Aerogels, Inc. has a twelve month low of $2.30 and a twelve month high of $9.35. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36. The stock has a fifty day simple moving average of $5.52 and a 200-day simple moving average of $4.53. The stock has a market capitalization of $483.83 million, a PE ratio of -3.81 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPNGet Free Report) last posted its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.The firm had revenue of $49.85 million for the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. On average, equities analysts forecast that Aspen Aerogels, Inc. will post -0.69 earnings per share for the current year.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

See Also

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.